Ticker Details
Larimar Therapeutics, Inc. Common Stock
IPO Date:	July 1, 2014
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$434.23M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.30 | 4.85%
Avg Daily Range (30 D):	$0.09 | 2.32%
Avg Daily Range (90 D):	$0.13 | 3.49%

Institutional Daily Volume
Avg Daily Volume:	.65M
Avg Daily Volume (30 D):	1.2M
Avg Daily Volume (90 D):	1.67M

Trade Size
Avg Trade Size (Sh.):	140
Avg Trade Size (Sh.) (30 D):	113
Avg Trade Size (Sh.) (90 D):	135

Institutional Trades
Total Institutional Trades:	300
Avg Institutional Trade:	$1.41M
Avg Institutional Trade (30 D):	$.69M
Avg Institutional Trade (90 D):	$1.15M
Avg Institutional Trade Volume:	.24M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.38M
Avg Closing Trade (30 D):	$.64M
Avg Closing Trade (90 D):	$1.16M
Avg Closing Volume:	266.61K

News

Jul 7, 2026 @ 10:04 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp

Feb 26, 2026 @ 1:59 AM Larimar Therapeutics Announces Pricing of Upsized ... Source: Globe Newswire

Feb 26, 2026 @ 1:59 AM Larimar Therapeutics Announces Pricing of Upsized ... Source: Na

Oct 16, 2025 @ 8:44 AM Larimar Therapeutics, Inc. Investigated for Securi... Source: Prnewswire

Oct 16, 2025 @ 1:30 AM Larimar Therapeutics, Inc. Investigated for Securi... Source: Business Wire

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS
Diluted EPS
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-172.61M	$-32.78M	$-29.61M
Operating Income / Loss	$-178.99M	$-34.35M	$-31.12M
Cost of Revenue
Net Cash Flow	$59.32M	$-85.38M	$92.5M
PE Ratio